CN110548078A - Composition containing Rutaceae plant extract - Google Patents
Composition containing Rutaceae plant extract Download PDFInfo
- Publication number
- CN110548078A CN110548078A CN201811022911.9A CN201811022911A CN110548078A CN 110548078 A CN110548078 A CN 110548078A CN 201811022911 A CN201811022911 A CN 201811022911A CN 110548078 A CN110548078 A CN 110548078A
- Authority
- CN
- China
- Prior art keywords
- plant extract
- rutaceae plant
- composition
- extract
- rutaceae
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241001093501 Rutaceae Species 0.000 title claims abstract description 85
- 239000000419 plant extract Substances 0.000 title claims abstract description 66
- 239000000203 mixture Substances 0.000 title claims abstract description 53
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 25
- 150000005846 sugar alcohols Polymers 0.000 claims abstract description 8
- 229920005862 polyol Polymers 0.000 claims description 38
- 150000003077 polyols Chemical class 0.000 claims description 38
- 239000003755 preservative agent Substances 0.000 claims description 33
- 239000002562 thickening agent Substances 0.000 claims description 30
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 25
- 230000002335 preservative effect Effects 0.000 claims description 22
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 21
- 239000000284 extract Substances 0.000 claims description 19
- 235000008733 Citrus aurantifolia Nutrition 0.000 claims description 10
- 235000005979 Citrus limon Nutrition 0.000 claims description 10
- 244000131522 Citrus pyriformis Species 0.000 claims description 10
- 240000000560 Citrus x paradisi Species 0.000 claims description 10
- 235000011941 Tilia x europaea Nutrition 0.000 claims description 10
- 235000011187 glycerol Nutrition 0.000 claims description 10
- 239000004571 lime Substances 0.000 claims description 10
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 8
- OEIJHBUUFURJLI-UHFFFAOYSA-N octane-1,8-diol Chemical compound OCCCCCCCCO OEIJHBUUFURJLI-UHFFFAOYSA-N 0.000 claims description 8
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 5
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 5
- 244000183685 Citrus aurantium Species 0.000 claims description 5
- 235000007716 Citrus aurantium Nutrition 0.000 claims description 5
- 244000175448 Citrus madurensis Species 0.000 claims description 5
- 241001672694 Citrus reticulata Species 0.000 claims description 5
- 240000002319 Citrus sinensis Species 0.000 claims description 5
- 235000005976 Citrus sinensis Nutrition 0.000 claims description 5
- 235000017317 Fortunella Nutrition 0.000 claims description 5
- 229920002907 Guar gum Polymers 0.000 claims description 5
- 244000179970 Monarda didyma Species 0.000 claims description 5
- 235000010672 Monarda didyma Nutrition 0.000 claims description 5
- OWBTYPJTUOEWEK-UHFFFAOYSA-N butane-2,3-diol Chemical compound CC(O)C(C)O OWBTYPJTUOEWEK-UHFFFAOYSA-N 0.000 claims description 5
- 239000000665 guar gum Substances 0.000 claims description 5
- 235000010417 guar gum Nutrition 0.000 claims description 5
- 229960002154 guar gum Drugs 0.000 claims description 5
- 229920002674 hyaluronan Polymers 0.000 claims description 5
- 229960003160 hyaluronic acid Drugs 0.000 claims description 5
- UWJJYHHHVWZFEP-UHFFFAOYSA-N pentane-1,1-diol Chemical compound CCCCC(O)O UWJJYHHHVWZFEP-UHFFFAOYSA-N 0.000 claims description 5
- 239000000843 powder Substances 0.000 claims description 5
- 239000000230 xanthan gum Substances 0.000 claims description 5
- 235000010493 xanthan gum Nutrition 0.000 claims description 5
- 229920001285 xanthan gum Polymers 0.000 claims description 5
- 229940082509 xanthan gum Drugs 0.000 claims description 5
- ACCCMOQWYVYDOT-UHFFFAOYSA-N hexane-1,1-diol Chemical compound CCCCCC(O)O ACCCMOQWYVYDOT-UHFFFAOYSA-N 0.000 claims description 4
- 239000004310 lactic acid Substances 0.000 claims description 4
- 235000014655 lactic acid Nutrition 0.000 claims description 4
- 229940080321 sodium anisate Drugs 0.000 claims description 4
- 229940058349 sodium levulinate Drugs 0.000 claims description 4
- AETSDHMVQHOYPB-UHFFFAOYSA-M sodium;4-methoxybenzoate Chemical compound [Na+].COC1=CC=C(C([O-])=O)C=C1 AETSDHMVQHOYPB-UHFFFAOYSA-M 0.000 claims description 4
- RDKYCKDVIYTSAJ-UHFFFAOYSA-M sodium;4-oxopentanoate Chemical compound [Na+].CC(=O)CCC([O-])=O RDKYCKDVIYTSAJ-UHFFFAOYSA-M 0.000 claims description 4
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims description 3
- GJVUMEONPPTZEY-UHFFFAOYSA-N 2,3-dihydroxypropyl undec-10-enoate Chemical compound OCC(O)COC(=O)CCCCCCCCC=C GJVUMEONPPTZEY-UHFFFAOYSA-N 0.000 claims description 3
- 244000215068 Acacia senegal Species 0.000 claims description 3
- 229920000084 Gum arabic Polymers 0.000 claims description 3
- 235000010489 acacia gum Nutrition 0.000 claims description 3
- 239000000205 acacia gum Substances 0.000 claims description 3
- 229940087068 glyceryl caprylate Drugs 0.000 claims description 3
- RGUVUPQQFXCJFC-UHFFFAOYSA-N n-hydroxyoctanamide Chemical compound CCCCCCCC(=O)NO RGUVUPQQFXCJFC-UHFFFAOYSA-N 0.000 claims description 3
- GHBFNMLVSPCDGN-UHFFFAOYSA-N rac-1-monooctanoylglycerol Chemical compound CCCCCCCC(=O)OCC(O)CO GHBFNMLVSPCDGN-UHFFFAOYSA-N 0.000 claims description 3
- 235000010413 sodium alginate Nutrition 0.000 claims description 3
- 239000000661 sodium alginate Substances 0.000 claims description 3
- 229940005550 sodium alginate Drugs 0.000 claims description 3
- 235000014104 aloe vera supplement Nutrition 0.000 claims description 2
- 240000006909 Tilia x europaea Species 0.000 claims 2
- 230000000694 effects Effects 0.000 abstract description 14
- 241000894006 Bacteria Species 0.000 abstract description 11
- 241000700605 Viruses Species 0.000 abstract description 7
- 230000001050 lubricating effect Effects 0.000 abstract description 7
- 230000003020 moisturizing effect Effects 0.000 abstract description 5
- 201000010099 disease Diseases 0.000 abstract description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 2
- 208000015181 infectious disease Diseases 0.000 abstract description 2
- 238000005461 lubrication Methods 0.000 abstract description 2
- 230000014759 maintenance of location Effects 0.000 abstract description 2
- 230000002265 prevention Effects 0.000 abstract description 2
- 230000009286 beneficial effect Effects 0.000 abstract 1
- 230000003115 biocidal effect Effects 0.000 abstract 1
- 230000000844 anti-bacterial effect Effects 0.000 description 27
- 239000000523 sample Substances 0.000 description 25
- 239000007864 aqueous solution Substances 0.000 description 24
- 230000000840 anti-viral effect Effects 0.000 description 9
- 238000004659 sterilization and disinfection Methods 0.000 description 9
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 8
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 8
- 244000089742 Citrus aurantifolia Species 0.000 description 8
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 239000000499 gel Substances 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 230000002421 anti-septic effect Effects 0.000 description 5
- 239000006286 aqueous extract Substances 0.000 description 5
- 239000012895 dilution Substances 0.000 description 5
- 238000010790 dilution Methods 0.000 description 5
- 239000000314 lubricant Substances 0.000 description 5
- -1 aloe extract Substances 0.000 description 4
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 4
- 229940067596 butylparaben Drugs 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 4
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 4
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 4
- 229920002545 silicone oil Polymers 0.000 description 4
- 208000031886 HIV Infections Diseases 0.000 description 3
- 241000713772 Human immunodeficiency virus 1 Species 0.000 description 3
- 229940069521 aloe extract Drugs 0.000 description 3
- 230000000845 anti-microbial effect Effects 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 230000002195 synergetic effect Effects 0.000 description 3
- 210000001215 vagina Anatomy 0.000 description 3
- MXOAEAUPQDYUQM-QMMMGPOBSA-N (S)-chlorphenesin Chemical compound OC[C@H](O)COC1=CC=C(Cl)C=C1 MXOAEAUPQDYUQM-QMMMGPOBSA-N 0.000 description 2
- 229940100555 2-methyl-4-isothiazolin-3-one Drugs 0.000 description 2
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 2
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 2
- 229940099451 3-iodo-2-propynylbutylcarbamate Drugs 0.000 description 2
- WYVVKGNFXHOCQV-UHFFFAOYSA-N 3-iodoprop-2-yn-1-yl butylcarbamate Chemical compound CCCCNC(=O)OCC#CI WYVVKGNFXHOCQV-UHFFFAOYSA-N 0.000 description 2
- 229940090248 4-hydroxybenzoic acid Drugs 0.000 description 2
- 229940100484 5-chloro-2-methyl-4-isothiazolin-3-one Drugs 0.000 description 2
- 239000005711 Benzoic acid Substances 0.000 description 2
- WSWCOQWTEOXDQX-MQQKCMAXSA-N E-Sorbic acid Chemical compound C\C=C\C=C\C(O)=O WSWCOQWTEOXDQX-MQQKCMAXSA-N 0.000 description 2
- XPJVKCRENWUEJH-UHFFFAOYSA-N Isobutylparaben Chemical compound CC(C)COC(=O)C1=CC=C(O)C=C1 XPJVKCRENWUEJH-UHFFFAOYSA-N 0.000 description 2
- CMHMMKSPYOOVGI-UHFFFAOYSA-N Isopropylparaben Chemical compound CC(C)OC(=O)C1=CC=C(O)C=C1 CMHMMKSPYOOVGI-UHFFFAOYSA-N 0.000 description 2
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 2
- 229960000583 acetic acid Drugs 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 235000010233 benzoic acid Nutrition 0.000 description 2
- 229960004365 benzoic acid Drugs 0.000 description 2
- 239000003093 cationic surfactant Substances 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- DHNRXBZYEKSXIM-UHFFFAOYSA-N chloromethylisothiazolinone Chemical compound CN1SC(Cl)=CC1=O DHNRXBZYEKSXIM-UHFFFAOYSA-N 0.000 description 2
- 229960003993 chlorphenesin Drugs 0.000 description 2
- 230000007797 corrosion Effects 0.000 description 2
- 238000005260 corrosion Methods 0.000 description 2
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 2
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 2
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 2
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 229940113094 isopropylparaben Drugs 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 2
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 2
- BEGLCMHJXHIJLR-UHFFFAOYSA-N methylisothiazolinone Chemical compound CN1SC=CC1=O BEGLCMHJXHIJLR-UHFFFAOYSA-N 0.000 description 2
- 229960002216 methylparaben Drugs 0.000 description 2
- 229960005323 phenoxyethanol Drugs 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 238000004321 preservation Methods 0.000 description 2
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 2
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 2
- 229960003415 propylparaben Drugs 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 229960004889 salicylic acid Drugs 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 229960003500 triclosan Drugs 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- HBOMLICNUCNMMY-XLPZGREQSA-N zidovudine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](N=[N+]=[N-])C1 HBOMLICNUCNMMY-XLPZGREQSA-N 0.000 description 2
- 229940043375 1,5-pentanediol Drugs 0.000 description 1
- RWLALWYNXFYRGW-UHFFFAOYSA-N 2-Ethyl-1,3-hexanediol Chemical compound CCCC(O)C(CC)CO RWLALWYNXFYRGW-UHFFFAOYSA-N 0.000 description 1
- NCZPCONIKBICGS-UHFFFAOYSA-N 3-(2-ethylhexoxy)propane-1,2-diol Chemical compound CCCCC(CC)COCC(O)CO NCZPCONIKBICGS-UHFFFAOYSA-N 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 206010047791 Vulvovaginal dryness Diseases 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 239000000935 antidepressant agent Substances 0.000 description 1
- 229940005513 antidepressants Drugs 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 239000012470 diluted sample Substances 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 229940100524 ethylhexylglycerin Drugs 0.000 description 1
- 229960005082 etohexadiol Drugs 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 229940051250 hexylene glycol Drugs 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 208000021822 hypotensive Diseases 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000009245 menopause Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 238000009806 oophorectomy Methods 0.000 description 1
- 229940127234 oral contraceptive Drugs 0.000 description 1
- 239000003539 oral contraceptive agent Substances 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 229960002555 zidovudine Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Virology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Toxicology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Medicines Containing Plant Substances (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention provides a composition containing Rutaceae plant extract, which comprises 0.1-2 wt% of Rutaceae plant extract, 10-30 wt% of C1-C4 polyalcohol system and 60-70 wt% of pure water. The composition containing the Rutaceae plant extract can resist bacteria and viruses in a short time, has lubricating and moisturizing effects, and is sanitary, safe and good in using effect. The invention has the beneficial effects of lubrication, moisture retention and the like, and has the effects of short-time antibiosis, virus resistance, disease infection prevention and the like.
Description
Technical Field
The invention relates to the field of Rutaceae plant extracts, and relates to a composition containing Rutaceae plant extracts.
Background
Natural acidic lubricating fluids normally exist in the vagina and are produced in increments when making love. For several reasons, including decreased estrogen during menopause, or following ovariectomy, and after radiation therapy, the lubricant may decrease, causing vaginal tissue to become dry and irritated. This can lead to pain and/or bleeding when making love. Oral contraceptives and certain drugs such as antihistamines, antidepressants, hypotensives and heart drugs also cause vaginal dryness. Additionally, psychological conditions, including stress, exertion, and anxiety, may hinder the production of natural lubricating fluids. After delivery, especially when the mother is nursing in person, the combination of hormones and psychological factors may induce a temporary dryness of the vagina.
Common personal lubricants or care and cleansing products, such as silicones and commercially available K-Y gels and petrolatum, are based primarily on synthetic materials such as silicones, petrochemical materials. Thus, such commercially available acidic vaginal lubricants are not recommended for use by women who want to become pregnant, or by groups who focus on natural organic, preventive care.
Disclosure of Invention
An object of the present invention is to provide a composition containing an extract of a rutaceae plant, which has not only a health-care effect of lubrication, moisture retention, etc., but also an antibacterial, antiviral, disease infection prevention, etc. effect for a short time.
In order to achieve the above objects, the present invention provides a composition containing rutaceae plant extract, comprising 0.1-2 wt% of rutaceae plant extract, 10-30 wt% of C1-C4 polyol system, and 60-70 wt% of pure water. In one aspect, the rutaceae plant extract-containing composition of the present invention comprises 0.1-2 wt% of rutaceae plant extract, 2-10 wt% of C5-C8 polyol system, and 60-70 wt% of pure water. In one aspect, the rutaceae plant extract is an extract selected from any one of the group consisting of oranges, mandarins, sweet oranges, lime, bitter oranges, pomelos, grapefruits, lemons, limes, lemons, bergamots, and kumquats. The polyol system is a composition selected from any one of the group consisting of glycerol, propylene glycol, methyl propylene glycol, butylene glycol, pentylene glycol, hexylene glycol, octylene glycol, and ethylhexylglycerin.
In order to achieve the above objects, the present invention provides another composition containing extracts of rutaceae plants, comprising 0.1 to 2 wt% of extracts of rutaceae plants; 10-30 wt% of a C1-C4 polyol system; 1-4 wt% of a natural preservative; 0.5-2 wt% of natural thickening agent and 60-70 wt% of pure water. In one aspect, the present invention relates to another composition comprising an extract of a rutaceae plant, comprising 0.1 to 2 wt% of the extract of the rutaceae plant; 2-10 wt% of a C5-C8 polyol system; 1-4 wt% of a natural preservative; 1-3 wt% of natural thickening agent and 60-70 wt% of pure water.
In one aspect, the rutaceae plant extract is an extract selected from any one of the group consisting of oranges, mandarins, sweet oranges, lime, bitter oranges, pomelos, grapefruits, lemons, limes, lemons, bergamots, and kumquats.
The C1-C4 polyol system is a composition selected from any one of the group consisting of glycerol, propylene glycol, methyl propylene glycol, and butylene glycol. The C5-C8 polyol system is a composition selected from any one of the group consisting of pentanediol, hexanediol, octanediol, and octanediol. The natural thickener is a composition selected from any one of the group consisting of xanthan gum, guar gum, sodium alginate and gum arabic. Depending on the purpose of use, non-natural thickeners may also be used.
The preservatives are, for example, sodium anisate and sodium levulinate; octanoyl hydroxamic acid and lactic acid; or glyceryl caprylate and glyceryl undecylenate. Suitable preservatives of the present invention may be acid preservatives such as hexadienoic acid, anhydrous acetic acid, benzoic acid, p-hydroxybenzoic acid or salicylic acid. Alternatively, the preservative of the present invention may be a paraben based preservative, such as methyl paraben, ethyl paraben, propyl paraben, butyl paraben, isopropyl paraben, isobutyl paraben or second butyl paraben. In addition, the preservative of the present invention may be methylisothiazolinone, methylchloroisothiazolinone ketone, iodopropynyl butylcarbamate, phenoxyethanol, chlorphenesin, triclosan, quaternary ammonium salts or cationic surfactants.
According to the composition containing the Rutaceae plant extract, hyaluronic acid powder, aloe extract, essential oil or essence and other anti-aging or whitening functional raw materials can be additionally added according to requirements. The composition containing the Rutaceae plant extract can resist bacteria and viruses in a short time, has lubricating and moisturizing effects, and is sanitary and safe; the use effect is good. In order to make the aforementioned objects, features and advantages of the present invention comprehensible, embodiments accompanied with figures are described in detail below. It is to be noted that the components in the attached drawings are merely schematic and are not shown in actual scale.
Drawings
FIG. 1 shows an aqueous solution of a pure Rutaceae plant extract (sample 1); polyol system, preservative and natural thickener (sample 2); and aqueous extracts of rutaceae plants, polyol systems, preservatives and natural thickeners (sample 3), respectively, for comparison against the HIV-1 virus test.
FIG. 2 is a graph showing the utilization of an 80-fold dilution of an aqueous solution of a pure Rutaceae plant extract (sample 1); polyol system, preservative and natural thickener (sample 2); and aqueous extracts of rutaceae plants, polyol systems, preservatives and natural thickeners (sample 3), respectively, to inhibit HIV-1 infection of jlrg CD4+ cells.
Detailed Description
One embodiment of the present invention relates to a composition containing Rutaceae plant extract, comprising 0.1-2 wt% of Rutaceae plant extract, 10-30 wt% of C1-C4 polyalcohol system and 60-70 wt% of pure water. In another embodiment, a composition comprising extracts of rutaceae plants comprises 0.1-2 wt% of rutaceae plant extracts, 2-10 wt% of a C5-C8 polyol system, and 60-70 wt% of purified water. In one embodiment, the rutaceae plant extract is an extract selected from any one of the group consisting of oranges, mandarins, sweet oranges, lime, bitter oranges, pomelos, grapefruits, lemons, limes, lemons, bergamots, and kumquats. The Rutaceae plant extract can open cell membrane of bacteria, allow other substances to enter, and enhance sterilization. In addition, the Rutaceae plant extract also has antiviral effect. The Rutaceae plant extract also has antibacterial and antiviral effects.
The C1-C4 polyol system is a composition selected from any one of the group consisting of glycerol, propylene glycol, methyl propylene glycol, and butylene glycol. The C5-C8 polyol system is a composition selected from any one of the group consisting of pentanediol, hexanediol, octanediol, and octanediol. The above polyols, such as propylene glycol, have a lubricating effect. The glycerin can absorb moisture in the air to moisturize the skin, can lock the moisture in the skin and prevent the moisture from losing, and has the moisturizing effect. In addition, these polyols all have the effect of "self-preservation", which can increase the antibacterial power and enhance the disinfection effect.
In another embodiment, the invention relates to a composition comprising extracts of rutaceae plants, comprising 0.1-2 wt% of rutaceae plant extracts; 10-30 wt% of a C1-C4 polyol system; 1-4 wt% of a preservative; 0.5-2 wt% of natural thickener and 60-70 wt% of pure water. In another embodiment, the rutaceae plant extract-containing composition of the present invention comprises 0.1 to 2 wt% of a rutaceae plant extract; 2-10 wt% of a C5-C8 polyol system; 1-4 wt% of a preservative; 1-3 wt% of natural thickener and 60-70 wt% of pure water. In one embodiment, the rutaceae plant extract is an extract selected from any one of the group consisting of oranges, mandarins, sweet oranges, lime, bitter oranges, pomelos, grapefruits, lemons, limes, lemons, bergamots, and kumquats. The Rutaceae plant extract can open cell membrane of bacteria, allow other substances to enter, and enhance sterilization. In addition, the Rutaceae plant extract also has antiviral effect.
The C1-C4 polyol system is a composition selected from any one of the group consisting of glycerol, propylene glycol, methyl propylene glycol, and butylene glycol. The C5-C8 polyol system is a composition selected from any one of the group consisting of pentanediol, hexanediol, octanediol, and octanediol. The above polyols, such as propylene glycol, have a lubricating effect. The glycerin can absorb moisture in the air to moisturize the skin, can lock the moisture in the skin and prevent the moisture from losing, and has the moisturizing effect. In addition, these polyols all have the effect of "self-preservation", which can increase the antibacterial power and enhance the disinfection effect.
The natural thickener is a composition selected from any one of the group consisting of xanthan gum, guar gum, sodium alginate and gum arabic. Depending on the purpose of use, non-natural thickeners may also be used.
The preservatives are, for example, sodium anisate and sodium levulinate; octanoyl hydroxamic acid and lactic acid; or glyceryl caprylate and glyceryl undecylenate. Suitable preservatives of the present invention may also be acid preservatives, for example hexadienoic acid, anhydrous acetic acid, benzoic acid, p-hydroxybenzoic acid or salicylic acid. Alternatively, the preservative of the present invention may also be a paraben preservative, such as methyl paraben, ethyl paraben, propyl paraben, butyl paraben, isopropyl paraben, isobutyl paraben or second butyl paraben. Further, suitable preservatives of the present invention may also be methylisothiazolinone, methylchloroisothiazolinone ketone, iodopropynyl butylcarbamate, phenoxyethanol, chlorphenesin, triclosan, quaternary ammonium salts or cationic surfactants.
According to the composition containing the Rutaceae plant extract, other auxiliary raw materials such as hyaluronic acid powder, aloe extract or essential oil and the like can be additionally added according to requirements, so that the antibacterial and antiviral effects are not influenced. The composition containing the Rutaceae plant extract can resist bacteria and viruses in a short time, has lubricating and moisturizing effects, and is sanitary and safe; the use effect is good.
Example 1: preparing aqueous solution of Rutaceae plant extract
In this example, three aqueous solutions of rutaceae plant extracts at different concentrations and pH values were used for the antibacterial activity test, with 0.5 v% and pH 2.5, 1 v% and pH 4.4 and 1 v% and pH 5.2, and the results of the test data are shown in table 1.
TABLE 1
As a result of the test data shown in Table 1, it was found that an aqueous solution of a Rutaceae plant extract having a concentration of 0.5 v% and a pH of 2.5 has a superior antibacterial activity, and that the antibacterial activity cannot be effectively improved if the concentration is increased to 1 v% while the pH must be increased in order to reduce the irritation of the vagina or the use of normal human skin by the composition containing the Rutaceae plant extract according to the present invention. The pH value of a common commercially available human lubricant product is 5-7, and according to detection data, the antibacterial power at pH 5.2 is the worst of three conditions, and the antibacterial power can not reach 99.9% of threshold within 20 minutes. According to the normal smearing and using time of the human body lubricant, the antibacterial power of 99.9 percent must be achieved by setting 20 minutes generally. The rutaceae plant extract diluted with water can have a general antibacterial activity at 0.5 v% and a pH of 2.5, but if the pH is within a general use range (pH 4-6) of a commercially available product, the antibacterial activity is significantly reduced, and even if the concentration is increased to 1 v%, the antibacterial activity is only 30-40%. Therefore, when the aqueous solution of the extract of the rutaceae plant is used and the pH is in the range of the general commercial product (pH 4-6), the antibacterial power is obviously insufficient.
Example 2: adding natural thickener into aqueous solution of Rutaceae plant extract
This example mixes a 1.55 wt% aqueous solution of a rutaceae plant extract with xanthan gum (0.4 wt%), guar gum (0.6 wt%), hyaluronic acid powder (0.05 wt%), aloe vera extract (0.1 wt%), vegetable glycerin (9.5%) and purified water to form a gel. The above-mentioned materials are basically natural materials which are easy to grow bacteria, except glycerin. The results of the test data are shown in table 2.
TABLE 2
The detection data results shown in table 2 show that the antibacterial power is obviously reduced or no antibacterial power, and the aqueous solution of the rutaceae plant extract cannot be used as the antibacterial and antiseptic of gel products, and even more specifically, the short-time sterilization and virus killing effect can be achieved. Therefore, when the aqueous solution of the extract of the rutaceae plant and the natural thickening agent which is easy to grow bacteria and not easy to store for a long time, such as xanthan gum, guar gum and the like, are mixed to prepare the gel, the result of the detection data shows that the antibacterial power is obviously insufficient, and even the bacteria resistance and the corrosion resistance are doubtful.
Example 3: adding aqueous solution of extract of Rutaceae plant into water and polyalcohol containing modified silicone oil as base
In this example, a 1 wt% aqueous solution of a rutaceae plant extract was added to a mixture of 80 wt% modified silicone oil of Dow Corning 2501, 9 wt% water and 10 wt% glycerin, the pH of the formulation was 4.5, and the results of the measurement data are shown in table 3.
TABLE 3
The detection data in table 3 show that 99.9% of antibacterial activity can be achieved in 20 minutes, which may be caused by the synergistic effect of the polyols on the effectiveness of the rutaceae plant extract or the synergistic effect of the polyols on the effectiveness of the rutaceae plant extract; and the rutaceae plant extract can not reach 99.9 percent of antibacterial effect under the condition that water is used as a substrate, but can be used under the modified silicone oil base, and the inherent disinfection effect of the rutaceae plant extract can be exerted only under the condition that bacteria and mildew do not grow or under the environment without nutrients available for microorganisms.
From the above examples, it is known that rutaceae plant extracts can achieve general antibacterial effects on water as a base, and can completely exert disinfection effects on modified silicone oil as a base, so that natural gels with disinfection effects are prepared, and not only is the antiseptic effect good, but also the proportion of the antiseptic and the polyhydric alcohol is adjusted to be synergistic, so that short-time antibacterial disinfection can be achieved.
Example 4: adding aqueous solution of extract of Rutaceae plant into water-based natural polyalcohol, natural thickener and natural antiseptic
In this example, the ingredients and the ratio of the aqueous solution of rutaceae plant extract to the water-based polyol, natural thickener and preservative are shown in table 4, and the results of the antibacterial activity test data are shown in table 5.
TABLE 4
TABLE 5
As shown in the data in Table 5, the formulation of example 4 has at least 99.9% of inhibition efficiency against four bacteria, namely Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa and Candida albicans, within 20 minutes.
The anti-HIV-1 virus test of the formulation of example 4 is described below. FIG. 1 shows a simple 1.35 wt% aqueous solution of a Rutaceae plant extract (sample 1); polyol system, preservative and natural thickener (sample 2); and comparison of rutaceae plant extract aqueous solutions, polyol systems, preservatives and natural thickeners (sample 3) against HIV-1 virus test. As can be seen from fig. 1, sample 3 is more effective against bacteria, corrosion and viruses than either sample 1 or sample 2.
FIG. 2 is a graph of a single 1.35 wt% aqueous solution of a Rutaceae plant extract (sample 1) using an 80-fold dilution; polyol system, preservative and natural thickener (sample 2); and comparison of the ability of aqueous rutaceae plant extract solutions, polyol systems, preservatives and natural thickeners (sample 3) to inhibit HIV-1 infection of JLTRG CD4+ cells. As seen in FIG. 2, sample 3 was more potent in antibacterial, preservative and antiviral effects than either sample 1 or sample 2, and had achieved the effect of eighty percent of Azidothymidine (AZT), a positive control drug.
Table 6 shows the 50% inhibitory concentration against HIV-1 infection for sample 3 as a dilution of sample 3.
TABLE 6
Cell line | IC50(dilution factor of sample 3) |
Magi-5 | 233 |
Jurkat(JLTRG) | 312 |
The foregoing examples show that the antimicrobial efficacy of the aqueous extract of rutaceae plants, the polyol system, the preservative and the thickener is better than that of the pure aqueous extract of rutaceae plants or the composition of natural thickener added to the aqueous extract of rutaceae plants, and the antimicrobial efficacy can reach 99.9%. In addition, taking HIV-1 test as an example, the antiviral effect of the composition of rutaceae plant extract aqueous solution, polyol system, preservative and natural thickener (sample 3) was better than that of the composition of rutaceae plant extract aqueous solution alone (sample 1) or the composition of polyol system, preservative and natural thickener (sample 2), and was about 80% of the antiviral ability of the positive control drug AZT, and the experimental conditions were 80 times diluted samples. Therefore, it is estimated that sample 3 has a very significant antibacterial and antiviral efficacy of 99.9% without dilution.
Example 5: adding aqueous solution of extract of Rutaceae plant into water-based solution containing polyalcohol, natural thickener and antiseptic
Example 5 the ingredients and proportions of the aqueous solution of rutaceae plant extract added to a water-based composition containing a polyol, a natural thickener, and a preservative are shown in table 7. Example 5 differs from example 4 in that it uses different polyols and can achieve the same level of antimicrobial effect in different proportions.
TABLE 7
Numbering | Composition (I) | wt% |
1 | Aqueous solution of extract of rutaceae plant | 1.5 |
2 | Aloe extract | 0.1 |
3 | Hyaluronic acid powder | 0.1 |
4 | Sodium anisate and sodium levulinate | 3.0 |
5 | Lactic acid | 0.2 |
6 | Sanxian glue | 2 |
7 | Pentanediol | 3.5 |
8 | Pure water | The rest(s) |
The composition containing the Rutaceae plant extract is suitable for various formulations, and is not suitable for being made into gel or cream products, unlike the situation that many disinfectants can only be made into aqueous solutions, or most cationic bactericides cannot be matched with most natural thickeners (most of which are anions), for example, products such as water spray, white factors, gold shields and the like which are sold in the market are in aqueous solution forms.
The above-described embodiments are merely exemplary for convenience of description, and various modifications may be made by those skilled in the art without departing from the scope of the invention as claimed in the claims.
Claims (10)
1. A composition containing Rutaceae plant extract is characterized by comprising 0.1-2 wt% of Rutaceae plant extract, 10-30 wt% of C1-C4 polyalcohol system and 60-70 wt% of pure water.
2. A composition containing Rutaceae plant extract is characterized by comprising 0.1-2 wt% of Rutaceae plant extract, 5-15 wt% of C5-C8 polyalcohol system and 60-70 wt% of pure water.
3. A composition containing Rutaceae plant extract is characterized by comprising 0.1-2 wt% of Rutaceae plant extract; 10-30 wt% of a C1-C4 polyol system; 1-4 wt% preservative; 0.5-2 wt% of natural thickening agent and 60-70 wt% of pure water.
4. A composition containing Rutaceae plant extract is characterized by comprising 0.1-2 wt% of Rutaceae plant extract; 2-10 wt% of a C5-C8 polyol system; 1-4 wt% preservative; 1-3 wt% of natural thickening agent and 60-70 wt% of pure water.
5. The composition of any one of claims 1 to 4, wherein the extract of a Rutaceae plant is an extract selected from any one of the group consisting of oranges, mandarins, sweet oranges, lime, bitter oranges, pomelos, grapefruits, lemons, lime, lemons, bergamots, and kumquats.
6. The rutaceae plant extract-containing composition of claim 1 or 3, wherein the C1-C4 polyol system is a composition selected from any one of the group consisting of glycerol, propylene glycol, methyl propylene glycol, and butylene glycol.
7. The rutaceae plant extract-containing composition of claim 2 or 4, wherein the C5-C8 polyol system is a composition selected from any one of the group consisting of pentanediol, hexanediol, octanediol, and octanediol.
8. The composition of claim 3 or 4, wherein the natural thickener is a composition selected from the group consisting of xanthan gum, guar gum, sodium alginate and gum arabic.
9. The composition of claim 3 or 4, wherein the preservative is selected from the group consisting of sodium anisate and sodium levulinate; octanoyl hydroxamic acid and lactic acid; or glyceryl caprylate and glyceryl undecylenate.
10. The rutaceae plant extract-containing composition of any one of claims 1-4, further comprising hyaluronic acid powder and aloe vera extract.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW107118821 | 2018-05-31 | ||
TW107118821A TWI731244B (en) | 2018-05-31 | 2018-05-31 | A composition containing a rutaceae plant extract |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110548078A true CN110548078A (en) | 2019-12-10 |
Family
ID=68736232
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811022911.9A Pending CN110548078A (en) | 2018-05-31 | 2018-09-03 | Composition containing Rutaceae plant extract |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN110548078A (en) |
TW (1) | TWI731244B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111888405A (en) * | 2020-09-14 | 2020-11-06 | 北京皓尔生物科技有限公司 | Traditional Chinese medicine composition for contracting and tightening vagina and preparation method and application thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102836247A (en) * | 2012-09-13 | 2012-12-26 | 苏州益洁生物科技有限公司 | Tangerine extract composition for feminite care |
CN107432890A (en) * | 2017-08-16 | 2017-12-05 | 青岛大师兄生物科技有限公司 | PH responsive type feminine care products and preparation method thereof |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103405592A (en) * | 2013-05-30 | 2013-11-27 | 李颖黄 | Bacteriostatic water-soluble personal lubricant and preparation method thereof, and condom |
-
2018
- 2018-05-31 TW TW107118821A patent/TWI731244B/en active
- 2018-09-03 CN CN201811022911.9A patent/CN110548078A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102836247A (en) * | 2012-09-13 | 2012-12-26 | 苏州益洁生物科技有限公司 | Tangerine extract composition for feminite care |
CN107432890A (en) * | 2017-08-16 | 2017-12-05 | 青岛大师兄生物科技有限公司 | PH responsive type feminine care products and preparation method thereof |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111888405A (en) * | 2020-09-14 | 2020-11-06 | 北京皓尔生物科技有限公司 | Traditional Chinese medicine composition for contracting and tightening vagina and preparation method and application thereof |
Also Published As
Publication number | Publication date |
---|---|
TW202003007A (en) | 2020-01-16 |
TWI731244B (en) | 2021-06-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106334067B (en) | Gynecological gel containing silver ion antibacterial agent, preparation method and application | |
JP2015178497A (en) | Semi-fluid composition used for lubrication, moisturization, disinfection or sterilization, and method of use thereof | |
DK3035915T3 (en) | Composition, in particular in the form of a gel, and its use | |
CN111789798A (en) | Bactericide containing aloe extract and preparation method thereof | |
WO1999037295A1 (en) | Method and composition for skin treatment | |
CN111110577B (en) | Mild mite-removing itching-relieving shower gel and preparation method thereof | |
CN104922055A (en) | Semifluid composition used for lubrication, moisture retention, disinfection and sterilization and application method thereof | |
CN110075046A (en) | It is a kind of can the light trace of Eradicates acne composition | |
EP3761945A1 (en) | Preservation of personal care compositions | |
CN110545825A (en) | Disinfecting composition | |
CN109453094B (en) | Mosquito-repelling and itching-relieving composition and skin care product containing composition | |
CN106619277A (en) | Silicone oil-free grease control anti-hair loss shampoo | |
CN110548078A (en) | Composition containing Rutaceae plant extract | |
CN112006921A (en) | Wash-free alcohol gel with skin care function and preparation method thereof | |
EP1980241A2 (en) | Wet wipes with vitex agnus castus extract for feminine personal care | |
RU2660347C1 (en) | Cosmetic composition against seborrheic manifestations on the skin | |
KR100785486B1 (en) | A substitute for preservatives in cosmetics and a cosmetic composition of nonpreservative containing the same | |
AU2019259322A1 (en) | Anti-perspirant preparation comprising alkaline-earth metal salts | |
US20190167549A1 (en) | Preservation booster | |
RU2811227C1 (en) | Antibacterial hand spray | |
WO2017041202A1 (en) | Compound having preservative quality and preparation and use thereof | |
US20150209401A1 (en) | Synergistic Multi-Active Composition for Topical Treatment of Disorders in Mammals, Use of Composition, and Method | |
WO2022000038A1 (en) | Sanitizing, antimicrobial hand, face and body moisturiser | |
JP2011079791A (en) | Skin disinfection preparation for external use | |
KR20220008719A (en) | Low concentration alcohol hand disinfection composition comprising carrageenan |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |